The first of nearly 10,000 lawsuits against DePuy Orthopaedics (a subsidiary of Johnson & Johnson) is set to begin this week. However, the manufacturer’s litigation strategy may change as newly released internal company documents show that the company knew that failure rates in its ASR (Articular Surface Replacement) hip implant devices would be high. Very high. In fact, the metal-on-metal hip replacement maker determined that nearly 40% of all ASR patients would experience a failure within five years – but… Read More
Category: <span>DePuy</span>
Driscoll of The Driscoll Firm, LLC, says the FDA’s proposal to require more stringent pre-market scrutiny of metal-on-metal hip implants won’t help those currently suffering health problems. St. Louis, MO (Vocus/PRWEB) February 1, 2013 – John J. Driscoll, a nationally recognized defective medical products attorney, said today that he endorses the U.S. Food and Drug Administration’s proposal to require metal-on-metal total hip replacement system manufacturers to submit premarket approval (PMA) applications for their products. “This would require artificial hip manufacturers… Read More
The first trial over Johnson & Johnson’s controversial DePuy hip implant device began last week – and 10,000 more lawsuits are still pending. The metal-on-metal hip implant device has been associated with failure rates as high as 49%, and new research continues to be published on the device’s link to metallosis (metal blood poisoning). Orthopedics Study Highlights Metallosis A recent study published in the December 2012 issue of the journal Orthopedics highlighted the issue of metallosis – a condition caused… Read More
